D. Sliva

发表

Mushroom Ganoderma lucidum Prevents Colitis-Associated Carcinogenesis in Mice

Jiri Adamec, George E. Sandusky, J. Adamec, 2012, PloS one.

Ganoderma lucidum suppresses motility of highly invasive breast and prostate cancer cells.

M. Sedlák, N. Ho, D. Sliva, 2002, Biochemical and biophysical research communications.

Protein Kinase C Induces Motility of Breast Cancers by Upregulating Secretion of Urokinase-Type Plasminogen Activator through Activation of AP-1 and NF-κB

D. Sliva, D. English, F. Lloyd, 2002 .

Synergistic and Additive Effects of Modified Citrus Pectin With Two Polybotanical Compounds, in the Suppression of Invasive Behavior of Human Breast and Prostate Cancer Cells

D. Sliva, Jiahua Jiang, Isaac Eliaz, 2013, Integrative cancer therapies.

ProstaCaid TM inhibits tumor growth in a xenograft model of human prostate cancer

G. Sandusky, C. Terry, D. Sliva, 2012 .

Biologic activity of spores and dried powder from Ganoderma lucidum for the inhibition of highly invasive human breast and prostate cancer cells.

M. Sedlák, N. Ho, D. Sliva, 2003, Journal of alternative and complementary medicine.

Natural compounds and combination therapy in colorectal cancer treatment.

A. Čumová, P. Vodicka, D. Sliva, 2018, European journal of medicinal chemistry.

Trimeric and Tetrameric A-Type Procyanidins from Peanut Skins.

J. Gliński, D. Sliva, M. Dudek, 2017, Journal of natural products.

Signaling pathways responsible for cancer cell invasion as targets for cancer therapy.

D. Sliva, D. Slíva, 2004, Current cancer drug targets.

Ganoderma lucidum for Cancer Treatment

D. Sliva, Shujie Cheng, D. Slíva, 2015, Integrative cancer therapies.

ReishiMax, mushroom based dietary supplement, inhibits adipocyte differentiation, stimulates glucose uptake and activates AMPK

D. Sliva, Anita Thyagarajan‐Sahu, Brandon S. Lane, 2011, BMC complementary and alternative medicine.

Migration of vascular smooth muscle cells induced by sphingosine 1-phosphate and related lipids: potential role in the angiogenic response.

P. Mcglynn, D. Brindley, D. Sliva, 2002, Experimental cell research.

Stable isotope-coded quaternization for comparative quantification of estrogen metabolites by high-performance liquid chromatography-electrospray ionization mass spectrometry.

F. Regnier, J. Adamec, D. Sliva, 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Suppression of cancer invasiveness by dietary compounds.

D. Sliva, D. Slíva, 2008, Mini reviews in medicinal chemistry.

The cellular mechanism of growth hormone signal transduction

M. Waters, N. Billestrup, B. Enberg, 1994, Acta paediatrica (Oslo, Norway : 1992). Supplement.

Role of Rho kinase in sphingosine 1-phosphate-mediated endothelial and smooth muscle cell migration and differentiation

D. Sliva, R. Siddiqui, Z. Welch, 2010, Molecular and Cellular Biochemistry.

Phosphatidylinositol 3-Kinase and NF-κB Regulate Motility of Invasive MDA-MB-231 Human Breast Cancer Cells by the Secretion of Urokinase-type Plasminogen Activator*

M. Rizzo, D. Sliva, D. English, 2002, The Journal of Biological Chemistry.

Tricyclic antidepressant binding to lymphocyte membranes and changes during depression.

D. Sliva, J. Sikora, K. Fuksová, 1988, European journal of pharmacology.

The binding of 3H digoxin by rat myocardial membranes in experimental cardiac hypertrophy

D. Sliva, V. Schreiber, F. Kölbel, 1985 .

Pachymic Acid Inhibits Growth and Induces Apoptosis of Pancreatic Cancer In Vitro and In Vivo by Targeting ER Stress

J. McClintick, G. Sandusky, D. Sliva, 2015, PloS one.

Effect of Phosphatidic Acid on Human Breast Cancer Cells Exposed to Doxorubicin

D. Sliva, D. English, K. Harvey, 2001, Cancer investigation.

BreastDefend™ prevents breast-to-lung cancer metastases in an orthotopic animal model of triple-negative human breast cancer

G. Sandusky, C. Terry, D. Sliva, 2012, Oncology reports.

BreastDefend TM prevents breast-to-lung cancer metastases in an orthotopic animal model of triple-negative human breast cancer

G. Sandusky, C. Terry, D. Sliva, 2012 .

Novel medicinal mushroom blend suppresses growth and invasiveness of human breast cancer cells.

D. Sliva, Jiahua Jiang, D. Slíva, 2010, International journal of oncology.

Phospholipids released from activated platelets improve platelet aggregation and endothelial cell migration

M. al-Hassani, D. Sliva, R. Siddiqui, 2001, Platelets.

Ganoderma lucidum in cancer research.

D. Sliva, D. Slíva, 2006, Leukemia research.

Anti-inflammatory activity of edible oyster mushroom is mediated through the inhibition of NF-κB and AP-1 signaling

J. Simon, Qingli Wu, D. Sliva, 2011, Nutrition journal.

Effect of immobilization stress on tricyclic antidepressant binding and serotonin uptake in rats.

D. Sliva, I. Farská, R. Krulík,, 1988, European journal of pharmacology.

14-3-3zeta interacts with the alpha-chain of human interleukin 9 receptor.

S. Tsai, Yuh Cheng Yang, D. Sliva, 2000, The Biochemical journal.

Specificity of transcription enhancement via the STAT responsive element in the serine protease inhibitor 2.1 promoter

B. Groner, A. Mui, G. Norstedt, 1997, Molecular and Cellular Endocrinology.

Cellular and physiological effects of Ganoderma lucidum (Reishi).

D. Sliva, D. Slíva, 2004, Mini reviews in medicinal chemistry.

Tissue invasion and metastasis: Molecular, biological and clinical perspectives.

A. Azmi, M. Ciriolo, A. Georgakilas, 2015, Seminars in cancer biology.

CDC20 associated with cancer metastasis and novel mushroom‑derived CDC20 inhibitors with antimetastatic activity.

D. Sliva, Shujie Cheng, Víctor Castillo, 2019, International journal of oncology.

Suppression of the inflammatory response by triterpenes isolated from the mushroom Ganoderma lucidum.

D. Sliva, S. Dudhgaonkar, A. Thyagarajan, 2009, International immunopharmacology.

Phellinus linteus suppresses growth, angiogenesis and invasive behaviour of breast cancer cells through the inhibition of AKT signalling

D. Sliva, A. Jedinák, J. Kawasaki, 2008, British Journal of Cancer.

Medicinal mushroom Phellinus linteus as an alternative cancer therapy.

D. Sliva, D. Slíva, 2010, Experimental and therapeutic medicine.

Ganoderic acids suppress growth and invasive behavior of breast cancer cells by modulating AP-1 and NF-kappaB signaling.

Brian C Grieb, D. Sliva, Jiahua Jiang, 2008, International journal of molecular medicine.

Ganoderma Lucidum(Reishi) in Cancer Treatment

D. Sliva, D. Slíva, 2003, Integrative cancer therapies.

The mushroom Ganoderma lucidum suppresses breast-to-lung cancer metastasis through the inhibition of pro-invasive genes

H. Nakshatri, G. Sandusky, Amanda Smith, 2014, International journal of oncology.

Triterpenes From Ganoderma Lucidum Induce Autophagy in Colon Cancer Through the Inhibition of p38 Mitogen-Activated Kinase (p38 MAPK)

C. Terry, D. Sliva, Jiahua Jiang, 2010, Nutrition and cancer.

Combined inhibition of invasive behavior of metastatic breast cancer cells by Ganoderma lucidum and green tea.

D. Sliva, A. Thyagarajan, 2006 .

Semisynthesis and biological evaluation of ganodermanontriol and its stereoisomeric triols.

R. Minto, D. Sliva, Jiahua Jiang, 2011, Journal of natural products.

Ganodermanontriol, a lanostanoid triterpene from Ganoderma lucidum, suppresses growth of colon cancer cells through ß-catenin signaling.

D. Sliva, Jiahua Jiang, A. Jedinák, 2011, International journal of oncology.

Ganoderma Lucidum induces oxidative DNA damage and enhances the effect of 5-Fluorouracil in colorectal cancer in vitro and in vivo.

Sona Vodenkova, A. Čumová, P. Vodicka, 2019, Mutation research.

Combined effect of green tea and Ganoderma lucidum on invasive behavior of breast cancer cells.

D. Sliva, A. Thyagarajan, Jiashi Zhu, 2007, International journal of oncology.

Inhibition of oxidative stress-induced invasiveness of cancer cells by Ganoderma lucidum is mediated through the suppression of interleukin-8 secretion.

J. Adamec, D. Sliva, Jiahua Jiang, 2006, International journal of molecular medicine.

Ganodermanontriol (GDNT) exerts its effect on growth and invasiveness of breast cancer cells through the down-regulation of CDC20 and uPA.

D. Sliva, Jiahua Jiang, A. Jedinák, 2011, Biochemical and biophysical research communications.

Ganoderma lucidum suppresses angiogenesis through the inhibition of secretion of VEGF and TGF-beta1 from prostate cancer cells.

D. Sliva, Jiahua Jiang, V. Slivova, 2005, Biochemical and biophysical research communications.

Designing a broad-spectrum integrative approach for cancer prevention and treatment.

Gloria S. Huang, Rob J. Kulathinal, C. Smythe, 2015, Seminars in cancer biology.

Suppression of growth and invasive behavior of human prostate cancer cells by ProstaCaid™: mechanism of activity.

D. Sliva, Jiahua Jiang, I. Eliaz, 2011, International journal of oncology.

Suppression of Proliferation and Invasive Behavior of Human Metastatic Breast Cancer Cells by Dietary Supplement BreastDefend

D. Sliva, A. Jedinák, Jiahua Jiang, 2011, Integrative cancer therapies.

Pleurotus ostreatus inhibits proliferation of human breast and colon cancer cells through p53-dependent as well as p53-independent pathway.

D. Sliva, A. Jedinák, D. Slíva, 2008, International journal of oncology.

Ganoderma lucidum inhibits proliferation and induces apoptosis in human prostate cancer cells PC-3.

D. Sliva, Jiahua Jiang, V. Slivova, 2004, International journal of oncology.

Triterpenes from Poria cocos suppress growth and invasiveness of pancreatic cancer cells through the downregulation of MMP-7

Junfang Lin, D. Sliva, Shujie Cheng, 2013, International journal of oncology.

Pleurotus ostreatus inhibits colitis-related colon carcinogenesis in mice.

G. Sandusky, D. Sliva, Jiahua Jiang, 2010, International journal of molecular medicine.

Regulation of NF-κB Function

R. K Srivastava, D. Sliva, D. Slíva, 2007 .

Phellinus linteus inhibits growth and invasive behavior of breast cancer cells through the suppression of Akt signaling.

D. Sliva, J. Kawasaki, V. Slivova, 2006 .

Gossypol inhibits growth, invasiveness, and angiogenesis in human prostate cancer cells by modulating NF-κB/AP-1 dependent- and independent-signaling

D. Sliva, Jiahua Jiang, A. Jedinák, 2011, Clinical & Experimental Metastasis.

The Use of Edible Mushroom Water Soluble Polysaccharides in the Treatment and Prevention of Chronic Diseases: A Mechanistic Approach

Y. Hadar, D. Sliva, B. Schwartz, 2013 .

Apurinic/Apyrimidinic endonuclease 1 regulates inflammatory response in macrophages.

M. Kelley, D. Sliva, A. Jedinák, 2011, Anticancer research.

Activated macrophages induce metastatic behavior of colon cancer cells.

D. Sliva, A. Jedinák, S. Dudhgaonkar, 2010, Immunobiology.

Honokiol inhibits migration of renal cell carcinoma through activation of RhoA/ROCK/MLC signaling pathway.

D. Sliva, Shujie Cheng, M. Welty, 2016, International journal of oncology.

Honokiol suppresses metastasis of renal cell carcinoma by targeting KISS1/KISS1R signaling

D. Sliva, Shujie Cheng, I. Eliaz, 2015, International journal of oncology.

Protein kinase C induces motility of breast cancers by upregulating secretion of urokinase-type plasminogen activator through activation of AP-1 and NF-kappaB.

D. Sliva, D. English, D. Lyons, 2002, Biochemical and biophysical research communications.

Gossypol inhibits growth, invasiveness, and angiogenesis in human prostate cancer cells by modulating NF-κB/AP-1 dependent- and independent-signaling

D. Sliva, Jiahua Jiang, A. Jedinák, 2012, Clinical & Experimental Metastasis.

Cellular and physiological effects of soy flavonoids.

D. Sliva, V. Slivova, Tatiana Valachovicova, 2004, Mini reviews in medicinal chemistry.

Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling.

D. Sliva, Jiahua Jiang, V. Slivova, 2006, International journal of oncology.

Green Tea Polyphenols Modulate Secretion of Urokinase Plasminogen Activator (uPA) and Inhibit Invasive Behavior of Breast Cancer Cells

Yung-Sheng Huang, D. Sliva, G. Zaloga, 2005, Nutrition and cancer.

Aspirin inhibits highly invasive prostate cancer cells.

D. Sliva, V. Slivova, Tatiana Valachovicova, 2003, International journal of oncology.